Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of 3 Doses of

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03592693` - Vitamin C, Hydrocortisone and Thiamine for Septic Shock	Phase 2
Terminated	`NCT01639664` - COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2	N/A
Withdrawn	`NCT01601938` - Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients	Phase 2
Recruiting	`NCT00335907` - Protocol-driven Hemodynamic Support for Patients With Septic Shock	N/A
Completed	`NCT00000574` - Ibuprofen in Sepsis Study	Phase 3
Recruiting	`NCT04910841` - Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine	N/A
Active, not recruiting	`NCT04079829` - Postoperative Respiratory Abnormalities
Recruiting	`NCT04569942` - Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis	Phase 3
Recruiting	`NCT04934943` - "Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools"
Completed	`NCT01310790` - Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock	Phase 4
Completed	`NCT00241228` - Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)	N/A
Completed	`NCT00046072` - A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis	Phase 2
Withdrawn	`NCT03122678` - Thiamine Supplementation in Patients With Septic Shock	Phase 1
Recruiting	`NCT06155812` - Multimodal Vasopressor Strategy in Septic Shock	Phase 2/Phase 3
Completed	`NCT04178148` - Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock	N/A
Completed	`NCT01453270` - Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial	N/A
Completed	`NCT04576819` - Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
Active, not recruiting	`NCT04055909` - Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock	Phase 2
Suspended	`NCT03193164` - Neuromuscular Electrical Stimulation and Septic Shock	N/A
Completed	`NCT04647552` - Effects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic Shock

NCT number	NCT03158948
Study type	Interventional
Source	Inotrem
Contact
Status	Completed
Phase	Phase 2
Start date	July 3, 2017
Completion date	June 13, 2018

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients With Septic Shock

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms